Clinical trial • Phase IV • Oncology

Clinical trial in Ovarian cancer

Phase IV trial for Ovarian cancer. 55 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Ovarian cancer
Trial Stage
Phase IV

Key dates

Initial CTIS Submission Date
18-07-2024
First CTIS Authorization Date
05-09-2024

Trial design

Phase IV trial across 5 sites in France.

Target Sample Size
55

Eligibility

Recruits 55 No vulnerable populations selected (isVulnerablePopulationSelected: false). Female-only population (isFemaleSubjects: true; isMaleSubjects: false)..

Vulnerable Population
No vulnerable populations selected (isVulnerablePopulationSelected: false). Female-only population (isFemaleSubjects: true; isMaleSubjects: false).

Recruitment

Planned Sample Size
55
Recruitment Window Months
136

Geography

Total Number Of Sites
5
Total Number Of Participants
55

France

Earliest CTIS Part Ii Submission Date
18-07-2024
Latest Decision Or Authorization Date
05-09-2024
Processing Time Days
49
Number Of Sites
5
Number Of Participants
55

Sites

Site Name
Institut Regional Du Cancer De Montpellier
Department Name
Surgery
Principal Investigator Name
Pierre-Emmanuel COLOMBO
Principal Investigator Email
Pierre-Emmanuel.Colombo@icm.unicancer.fr
Contact Person Name
Pierre-Emmanuel COLOMBO
Site Name
Hospices Civils De Lyon
Department Name
Surgery
Principal Investigator Name
Olivier GLEHEN
Principal Investigator Email
olivier.glehen@chu-lyon.fr
Contact Person Name
Olivier GLEHEN
Contact Person Email
olivier.glehen@chu-lyon.fr
Site Name
Centre Hospitalier Universitaire De Nice
Department Name
Surgery
Principal Investigator Name
Jean-Marc BEREDER
Principal Investigator Email
bereder.jm@chu-nice.fr
Contact Person Name
Jean-Marc BEREDER
Contact Person Email
bereder.jm@chu-nice.fr
Site Name
Institut Bergonie
Department Name
Surgery
Principal Investigator Name
Frédéric GUYON
Principal Investigator Email
F.Guyon@bordeaux.unicancer.fr
Contact Person Name
Frédéric GUYON
Contact Person Email
F.Guyon@bordeaux.unicancer.fr
Site Name
Oncopole Claudius Regaud
Department Name
Surgery
Principal Investigator Name
Gwenaël FERRON
Principal Investigator Email
Ferron.Gwenael@iuct-oncopole.fr
Contact Person Name
Gwenaël FERRON

Sponsor

Primary sponsor

Full Name
Institut Regional Du Cancer De Montpellier
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Related trials

Other published trials that may interest you.